Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Fish and Richardson
McKinsey
Queensland Health
Fuji
Baxter
Cipla
Teva
Merck
Cantor Fitzgerald

Generated: December 11, 2017

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Switzerland Patent: 01 996/99

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
Astrazeneca PharmsDALIRESProflumilastTABLET;ORAL022522-001Feb 28, 2011RXYesYes► Subscribe► Subscribe► SubscribeYYTREATMENT TO REDUCE THE RISK OF COPD EXACERBATIONS IN PATIENTS WITH SEVERE COPD ASSOCIATED WITH CHRONIC BRONCHITIS AND A HISTORY OF EXACERBATIONS
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist